Drug Discovery Services Market upto 2023: Top Companies, Growth Factors Details and Regional Overvie

By Bhagyashribhole    16 / May / 2018    In Category Healthcare

Drug Discovery Services Market Growing at CAGR of 10.8% during forecasted period. Actually Drug discovery is the process of designing a new drug. The most common methods employed for drug discovery are molecular manipulation, random screening, drug metabolites, molecular designing, and serendipity. Drug discovery services are specifically designed to minimize the costs and timelines of drug discovery.

Owing to the rising demand for cancer treatment, technological advancements, increasing healthcare expenditure, growing awareness about chronic diseases, increasing patient pool, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the Drug Discovery Services Market has evolved significantly.

However, huge capital investments with low-profit margins, strict FDA regulations, and poor healthcare system in the low and middle-income countries are likely to hamper the growth of the Drug Discovery Services Market over the forecast period.

It is estimated that the Drug Discovery Services Market is expected to grow at a CAGR 10.8% during the forecast period of 2017–2023.

Get PDF Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5870 .

Key Players for Global Drug Discovery Services Market

Some of the key players in the Global Drug Discovery Services Market are Abbott Laboratories Inc., Advinus Therapeutics, Agilent Technologies Ubiquigent, Albany Molecular Research Inc. (AMRI), AstraZeneca PLC, Aurigene, Bayer AG, Charles River Laboratories International, ChemBridge Corporation, Covance, Eli Lilly and Company, Evotec, Domainex, F. Hoffmann-La Roche Ltd, GE Healthcare, GenScript, GlaxoSmithKline LLC, GVK Biosciences, Jubilant Biosys, Lonza, Merck, Pharmaceutical Product Development, LLC (PPD), Piramal Enterprises, Promega Corporation, Selcia Limited, Shimadzu Corp., SRI International, Syngene International Ltd., Thermo Fisher Scientific, Viva Biotech, WuXi AppTec, and others.

Segments for Global Drug Discovery Services Market

The Global Drug Discovery Services Market is segmented by drug type, type of services, technology, therapeutic area, process, and end-user.

On the basis of drug type, the Drug Discovery Services Market is classified as small molecule drug and biologics drug, on the basis of types of services, the Drug Discovery Services Market is classified as Drug Metabolism and Pharmacokinetics (DMPK) services, pharmaceutical services, medicinal chemistry, and biological services.

On the basis of technology, the Drug Discovery Services Market is classified as high throughput screening, biochips, pharmacogenomics and pharmacogenetics, combinatorial chemistry, nanotechnology, spectroscopy, metabolomics, and others, on the basis of therapeutic area, the Drug Discovery Services Market is classified as oncology, neurology, cardiovascular diseases, respiratory diseases, diabetes, and others.

On the basis of process, the Drug Discovery Services Market is classified as target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation, on the basis of end-user, the Drug Discovery Services Market is segmented into hospitals and clinics, pharmaceutical companies, biotechnology companies, research institutes, and others.

Regional Analysis for Global Drug Discovery Services Market

The Americas dominates the Drug Discovery Services Market owing to the increasing prevalence of chronic diseases and high healthcare expenditure. According to the data suggested by the Center for Disease Control and Prevention (CDC), around 92.1 million adults have at least one type of cardiovascular disease.

Europe holds the second position in the Drug Discovery Services Market. The financial support by the government towards research and development and patent expiration of various blockbuster drugs are expected to drive the European Drug Discovery Services Market

Asia Pacific is the fastest growing Drug Discovery Services Market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific.

The Middle East and Africa holds the lowest share of the Global market due to slow development, lack of technical knowledge, and poor medical facilities.

Get Prime Discount on Report https://www.marketresearchfuture.com/check-discount/5870 .

Some Brief Table of Contents of Report

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

TOC Continued…

For Enquiry Related Report Click @ https://www.marketresearchfuture.com/enquiry/5870 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com